Q06145 AF NFT

Gastric inhibitory polypeptide

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigmvagvuy6i5ttv7jeknnvo7kkf5zfbcsvrh6rgvzcydxolnrveru/metadata.json
IPFS of structure file: 
bafybeiab2ld2uzqjqfsgnijdu6peufn2m4vj6fnnjsc6rf2ysdp4ptivii/AF-Q06145-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5e17C80A3064A18cE97C3a90e5C69D9a222F548e
First NFT owner address (bech32): 
genesis1tctusz3svjsce6tu82gwt35ang3z74ywa9z6gx
Current NFT ID #147440 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
147440
Accession (UniProt):
Q06145
Name::
Gastric inhibitory polypeptide
Experimental Method:
Predicted structure
Sequence source:
RATTUS NORVEGICUS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q06145 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q06145|GIP_RAT Gastric inhibitory polypeptide OS=Rattus norvegicus OX=10116 GN=Gip PE=2 SV=2 MVALKTCSLLLVLLFLAVGLGEKEEVEFRSHAKFAGPRPRGPRYAEGTFISDYSIAMDKIRQQDFVNWLLAQKGKKNDWKHNLTQREARALELAGQSQRNEEKEAQGSSLPKSLSDEDVLRDLLIQELLAWMADQAELCRLRSQ